Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19
Paulina Kapłonek(Moderna Therapeutics (United States)), Galit Alter(Moderna Therapeutics (United States)), Marcia B. Goldberg(Broad Institute), Kathryn Bowman(Ragon Institute of MGH, MIT and Harvard), Jaewon Kang(Ragon Institute of MGH, MIT and Harvard), Diana Dayal(SpaceX (United States)), Aaron G. Schmidt(Icahn School of Medicine at Mount Sinai), Jared Feldman(Ragon Institute of MGH, MIT and Harvard), Nir Hacohen(Cambridge Hospital), Matthew J. Gorman(Ragon Institute of MGH, MIT and Harvard), Eric J. Nilles(Brigham and Women's Hospital), Douglas A. Lauffenburger(Harvard University), Stephanie Fischinger(Leiden University), Chuangqi Wang(Massachusetts Institute of Technology), Michael R. Filbin(Brigham and Women's Hospital), Elon R. Musk(SpaceX (United States)), Radosław P. Nowak(Harvard University), Yannic C. Bartsch(Ragon Institute of MGH, MIT and Harvard), Patrick Martin(Université d'Artois), Ching‐Lin Hsieh(Asia University), Anil Menon(SpaceX (United States)), Jason S. McLellan(The University of Texas at Austin), Boris Jülg(Ragon Institute of MGH, MIT and Harvard), Eric S. Fischer(Dana-Farber Cancer Institute)
Cited by 16
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
|Nature|2009|4.2k